United States News Todas as matérias

Sierra Bancorp (NASDAQ:BSRR), parent company of Bank of the Sierra, reported second-quarter 2026 net income of $9.9 million, or $0.77 per diluted share, compared with $10.6 million, or $0.78 per share, in the second quarter of 2025.

Citizens Community Bancorp (NASDAQ:CZWI) reported second-quarter 2026 net income of $1.1 million following higher credit loss provisions.

Bank of Marin Bancorp (NASDAQ:BMRC) reported second-quarter 2026 net income of $9.2 million, or $0.58 per share, compared with a loss in the same period last year.

Hope Bancorp (NASDAQ:HOPE), the holding company of Bank of Hope, reported second-quarter 2026 net income of $33 million, or $0.26 per diluted common share, compared with a net loss of $24.8 million, or $0.19 per share, in the second quarter of 2025.

Luxfer Holdings (NYSE:LXFR) has entered into a definitive agreement to be acquired by affiliates of Wynnchurch Capital in an all-cash transaction that will pay shareholders $17.37 per ordinary share.

Northeast Bank (NASDAQ:NBN) reported a fourth-quarter net income of $34.3 million for the period ended June 30, 2026.

Ponce Financial Group (NASDAQ:PDLB) reported second-quarter common-stockholder net income of $8.2 million, up 41%, with diluted EPS of $0.35.

TransDigm Group (NYSE:TDG) agreed to acquire Prince & Izant for approximately $1.066 billion in cash, including certain tax benefits.

Honeywell Technologies (NASDAQ:HON) completed its all-cash WWS sale to American Industrial Partners, with financial terms undisclosed.

Costamare (NYSE:CMRE) reported second-quarter net income from continuing operations of $83.9 million and liquidity of $423 million.

Gossamer Bio (NASDAQ:GOSS) has announced a series of strategic and regulatory updates, highlighted by plans to submit a New Drug Application (NDA) for its lead candidate, seralutinib, in September 2026.

Alliance Resource Partners (NASDAQ:ARLP) reported second-quarter revenue of $551.6 million, up 0.7%, while net income increased 33.9% to $79.6 million.

Biohaven (NYSE:BHVN) and Yale University announced a favorable verdict from a federal jury in the U.S. District Court for the District of Delaware regarding their ongoing litigation against Avilar Therapeutics and RA Capital.

Bank of Hawai‘i (NYSE:BOH) reported second-quarter net income of $63.8 million, up 11.1% sequentially, with diluted EPS of $1.47.

Kura Oncology (NASDAQ:KURA) reported 33%–50% response rates for darlifarnib plus cabozantinib among 34 evaluable advanced kidney-cancer patients.

Perfect Corp. (NYSE:PERF) reported second-quarter net income of $1.3 million, up 518.4%, while revenue remained stable at $16.3 million.

Legend Biotech (NASDAQ:LEGN) announced a significant leadership transition, confirming that Ying Huang, Ph.D., has stepped down from his role as Chief Executive Officer and as a member of the Board of Directors, effective July 24, 2026.

The Ensign Group (NASDAQ:ENSG) reported second-quarter revenue of $1.44 billion, up 17.3%, as occupancy and skilled-care revenue increased.

Rocket Lab (NASDAQ:RKLB) won a $266 million Space Force contract covering 12 suborbital vehicles and six optional launches.

IDEAYA Biosciences (NASDAQ:IDYA) announced the initiation of the Part 2 monotherapy expansion for its Phase 1/2 clinical trial evaluating IDE892.

AstraZeneca (NYSE:AZN) reported second-quarter core EPS of $2.63, up 21%, as oncology and rare-disease sales grew.

The9 (NASDAQ:NCTY) reported its first-quarter 2026 financial results, generating an unaudited net income of $23 million for the period ended March 31, 2026.

argenx (NASDAQ:ARGX) agreed to acquire Forte Biosciences (NASDAQ:FBRX) for $77 per share, valuing the company at $2.2 billion.

TotalEnergies (NYSE:TTE) will appeal a court order requiring Scope 3 climate risks in its vigilance plan within six months.